Search - tctmd.com

Displaying 201 - 220 of 2676

Sort: Relevancy | Date

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

News Daily News

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

April 17, 2024

Antihypertensives Linked to Lower Long-term Dementia Risk

News Daily News

Antihypertensives Linked to Lower Long-term Dementia Risk

April 01, 2024

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

March 25, 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

March 15, 2024

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

Plastic Debris Found in Carotid Plaque Linked to More Adverse CV Events

News Daily News

Plastic Debris Found in Carotid Plaque Linked to More Adverse CV Events

March 06, 2024

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

News Daily News

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

February 28, 2024

Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study

News Daily News

Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study

February 28, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

One in Three Overweight MI Patients May Benefit From Semaglutide

News Daily News

One in Three Overweight MI Patients May Benefit From Semaglutide

February 26, 2024

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Niacin, When Broken Down by the Body, Can Spur Inflammation

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

February 22, 2024

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

News Daily News

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

February 14, 2024

Study IDs Patients Most Likely to Quit Smoking After ASCVD Event

News Daily News

Study IDs Patients Most Likely to Quit Smoking After ASCVD Event

Yael L. Maxwell

February 14, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

February 13, 2024

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

February 02, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.